Recursion director covers taxes with 22,821 shares
Recursion Pharmaceuticals director Christopher Gibson reported a routine tax-withholding transaction involving Class A Common Stock.
Rhea-AI Filing Summary
Recursion Pharmaceuticals director Christopher Gibson reported a routine tax-withholding transaction involving Class A Common Stock. On the reported date, 22,821 shares of Class A Common Stock were withheld at $3.04 per share to satisfy tax obligations from the net settlement of restricted stock units, rather than through an open-market sale.
After this withholding, Gibson directly held 883,735 Class A Common shares. The filing also lists various stock option grants with exercise prices between $2.48 and $11.40 per share and expirations from 2030 to 2035, as well as Class B Common Stock held indirectly through the Gibson Family Trust and LAHWRAN-3 and LAHWRAN-4 LLCs.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Class A Common Stock | 22,821 | $3.04 | $69K |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
Footnotes (10)
- F1. Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
- F2. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
- F3. The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
- F4. The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
- F5. The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.
- F6. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- F7. The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- F8. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- F9. The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- F10. The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
Key Figures
Key Terms
restricted stock units financial
Stock Option (Right to Buy financial
Class B Common Stock financial
tax withholding and remittance obligations financial
FAQ
What did Christopher Gibson report in this RXRX Form 4 filing?
Is the Form 4 transaction for RXRX an open-market sale by Christopher Gibson?
What stock options for RXRX does Christopher Gibson have referenced in this filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.